Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Contingent Liabilities ₹515 Cr₹456 Cr₹387 Cr₹354 Cr₹355 Cr

What is the latest Contingent Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹515 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹515 Cr
Mar2025₹456 Cr
Mar2024₹387 Cr
Mar2023₹354 Cr
Mar2022₹355 Cr

How is Contingent Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2026 ₹515 Cr
12.92
Mar2025 ₹456 Cr
17.78
Mar2024 ₹387 Cr
9.46
Mar2023 ₹354 Cr
-0.26
Mar2022 ₹355 Cr -

Compare Contingent Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹42,771.0 Cr 0.7% -9.3% -3.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr 2.7% 1.4% 4.3% Stock Analytics
DIVIS LABORATORIES ₹273,565.0 Cr 4.5% 6.3% 50.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,332.0 Cr 1.8% -1.3% 31.4% Stock Analytics
DR REDDYS LABORATORIES ₹114,532.0 Cr 0.8% 12.5% 14.1% Stock Analytics
CIPLA ₹113,831.0 Cr 1.6% 4.4% -9.1% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

0.7%

-9.3%

-3.3%

SENSEX

8.8%

10.9%

-4%


You may also like the below Video Courses